The Cervical Cancer Research Network (Gynecologic Cancer InterGroup) roadmap to expand research in low- and middle-income countries.

There are clearly significant synergies to be wrought from these international collaborations, and we are already exploring this approach with several pharmaceutical companies that are keen to include low- and middle-income countries in their trials, as we persist in our efforts to reduce the worldwide mortality and morbidity of cervical cancer.

also in 627 other papers